Mark F van Delft
9PUBLICATIONS
46CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Apr 09, 2025
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins.Jia-Nan Gong, Tirta M Djajawi, Donia M Moujalled
|Mar 05, 2025
Differential regulation of BAX and BAK apoptotic activity revealed by small molecules.Kaiming Li, Yu Q Yap, Donia M Moujalled
|Sep 28, 2022
Mitochondrial E3 ubiquitin ligase MARCHF5 controls BAK apoptotic activity independently of BH3-only proteins.Allan Shuai Huang, Hui San Chin, Boris Reljic
|Apr 02, 2022
The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL.Annette V Jacobsen, Catia L Pierotti, Kym N Lowes
|May 26, 2021
Too much death can kill you: inhibiting intrinsic apoptosis to treat disease.Kaiming Li, Mark F van Delft, Grant Dewson
|Feb 26, 2020
MARCH5 requires MTCH2 to coordinate proteasomal turnover of the MCL1:NOXA complex.Tirta Mario Djajawi, Lei Liu, Jia-Nan Gong
Pageof 2
Frequent Collaborators
5 joint publications
David C S Huang
5 joint publications
Guillaume Lessene
3 joint publications
Grant Dewson
3 joint publications
Benjamin T Kile
2 joint publications
Kate McArthur
2 joint publications
Kaiming Li
2 joint publications
Peter E Czabotar
2 joint publications
Andre L Samson
2 joint publications
Hui San Chin
2 joint publications
Michael T Ryan
